| scholarly article | Q13442814 |
| P50 | author | David A. Dichek | Q124980566 |
| Nagadhara Dronadula | Q124980778 | ||
| P2093 | author name string | Bradley K Wacker | |
| Lianxiang Bi | |||
| Emma Bueren | |||
| Ervin Ham | |||
| P2860 | cites work | A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics | Q28141424 | ||
| Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial | Q28286188 | ||
| KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis | Q30299921 | ||
| Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammalian species: reference values and comparison of data. | Q30789565 | ||
| Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth | Q34075485 | ||
| Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial cell-targeted gene therapy | Q34382972 | ||
| Understanding and treating vein graft atherosclerosis | Q34934966 | ||
| Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteries | Q34993431 | ||
| Efficient gene transfer and durable transgene expression in grafted rabbit veins | Q34999733 | ||
| Helper-dependent adenoviral vector achieves prolonged, stable expression of interleukin-10 in rabbit carotid arteries but does not limit early atherogenesis | Q35174913 | ||
| Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. | Q45641769 | ||
| Gene transfer to coronary artery bypass conduits | Q45855790 | ||
| Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis | Q45862703 | ||
| Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors | Q45868359 | ||
| Improved vascular gene transfer with a helper-dependent adenoviral vector | Q45877388 | ||
| Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels. | Q45884821 | ||
| Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates | Q45887087 | ||
| Gene therapy and vein graft patency in coronary artery bypass graft surgery | Q45888569 | ||
| Antiinflammatory actions of HDL: a new insight | Q46301862 | ||
| High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
| Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function | Q47904531 | ||
| Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis | Q64378257 | ||
| Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model | Q64379606 | ||
| Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia | Q64379705 | ||
| Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts | Q64381994 | ||
| The severity of atherosclerosis at sites of plaque rupture with occlusive thrombosis in saphenous vein coronary artery bypass grafts | Q68024894 | ||
| Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts | Q68156084 | ||
| Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit | Q69657544 | ||
| The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts | Q71966442 | ||
| The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graft | Q74131957 | ||
| Patencies of 2127 arterial to coronary conduits over 15 years | Q75271509 | ||
| Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells | Q82874756 | ||
| Understanding saphenous vein graft patency | Q84570510 | ||
| Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial | Q85015350 | ||
| ??? | Q28074173 | ||
| Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia | Q35769081 | ||
| A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal | Q35915922 | ||
| Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions | Q36126274 | ||
| Radial artery vs saphenous vein graft used as the second conduit for surgical myocardial revascularization: long-term clinical follow-up | Q36164691 | ||
| Cholesterol efflux analyses using stable isotopes and mass spectrometry | Q36480687 | ||
| Atherosclerosis: Successes, Surprises, and Future Challenges | Q36602802 | ||
| Gene therapy for the prevention of vein graft disease | Q36698258 | ||
| Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery | Q36975536 | ||
| Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy | Q37078225 | ||
| Characterization of rabbit CD5 isoforms | Q37377078 | ||
| Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV tr | Q37485187 | ||
| Improved animal models for testing gene therapy for atherosclerosis. | Q37710663 | ||
| Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries | Q37772604 | ||
| Gene delivery strategies targeting stable atheromatous plaque | Q38046954 | ||
| Gene therapy for cardiovascular disease: perspectives and potential | Q38059008 | ||
| Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions | Q38098012 | ||
| Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials | Q38128022 | ||
| Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy | Q38302443 | ||
| Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial | Q38411135 | ||
| Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial. | Q38495903 | ||
| Global and regional patterns in cardiovascular mortality from 1990 to 2013. | Q38616787 | ||
| Endothelial fluid shear stress sensing in vascular health and disease. | Q38630594 | ||
| Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis | Q38647828 | ||
| Cardiovascular Gene Therapy: Past, Present, and Future | Q38733395 | ||
| Coronary-Artery Bypass Grafting | Q38837494 | ||
| Vein graft failure: from pathophysiology to clinical outcomes. | Q38837879 | ||
| Stable In Vivo Transgene Expression in Endothelial Cells with Helper-Dependent Adenovirus: Roles of Promoter and Interleukin-10. | Q39189210 | ||
| Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts | Q39501012 | ||
| Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease | Q39641675 | ||
| Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy | Q39876759 | ||
| Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts | Q40427394 | ||
| High Pulsatility Flow Induces Acute Endothelial Inflammation through Overpolarizing Cells to Activate NF-κB. | Q40464742 | ||
| Coronary artery bypass graft disease. | Q40474971 | ||
| Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia | Q40534630 | ||
| Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre. | Q41152221 | ||
| Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
| HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization | Q42050958 | ||
| Atherosclerosis in rabbit vein grafts | Q43876879 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| P921 | main subject | Adenoviridae | Q193447 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 96-111 | |
| P577 | publication date | 2017-09-28 | |
| P1433 | published in | Molecular Therapy. Methods & Clinical Development | Q27725341 |
| P1476 | title | A Rabbit Model for Testing Helper-Dependent Adenovirus-Mediated Gene Therapy for Vein Graft Atherosclerosis | |
| P478 | volume | 7 |
| Q57046350 | ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation | cites work | P2860 |
Search more.